Journals / Anadolu Tıp Dergisi / 2003 / Cilt: 5 - Sayı: 2

Apocrine carcinoma (Report of six cases)

Apokrin karsinom (Altı olgu sunumu)

Pages
83–87
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this study, six cases of apocrine carcinoma were presented.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Apocrine carcinoma is a very rare form of breast malignancy.
📊
Key Findings & Data:The reported incidence of apocrin carcinoma is approximately 0,4 % of mammary carcinomas.
💡
Conclusion & Impact:In this study, six cases of apocrine carcinoma were presented.
🔬Design:Review & Systematic Survey
📍Scope:2000 Verileri
⚙️Variables:Domain Parameters

Abstract

Apocrine carcinoma is a very rare form of breast malignancy. The reported incidence of apocrin carcinoma is approximately 0,4 % of mammary carcinomas. In this retrospective study, the histologic sections of six cases with a diagnosis of apocrine carcinoma were reviewed according to age, tumor size, lymph node status and tumor localization in the pathology department of Dicle University School of Medicine between January 2000 and March 2003 and discussed the datas in literature. Sections obtained from routinely fixed and paraffin embedded material were stained histochemically Periodic acid-Schiff (PAS) and immunohistochemically for estrogen receptor (ER), progesterone receptor (PR) and bcl-2. Five patients were female and one was male. The youngest patients was 34 years old and the oldest patient was 77 (mean age 53.6). The size of the tumors varied between 1 cm to 10 cm in diameter (mean diameter 6.1 cm). Three of all cases were in the upper outer quadrant, two of all cases in the lower outer quadrant,one of all cases in the right of the nipple. Lymph node metastasis were detected in four cases. In hematoxylin eosin (HE) examination, large and round with abundant granular eosinophilic cytoplasm, the centrally to located nuclei are prominent eosinophilic nucleoli, tumor composed of solid mass and cords apocrine cells observed. PAS is positive, ER, progesterone receptor PR and bcl-2 are negative. In this study, six cases of apocrine carcinoma were presented.

Özet

Apokrin karsinom, meme karsinomlarının çok nadir bir formudur. Meme karsinomlarınm yaklaşık %0.4'ünü oluşturduğu bildirilmiştir. Retrospektif çalışmamızda 2000 Ocak - 2003 Mart tarihleri arasında Dicle Üniversitesi Patoloji Anabilim Dalında apokrin karsinom tanısı alan altı olgunun histolojik kesitleri, hasta yaşı, tümör boyutu, aksiller lenf nodu tutulumu, tümör lokalizasyonu yeniden değerlendirerek literatür verileri ile tartışmayı planladık. Parafın bloklarından elde edilen kesitlere histokimyasal olarak Periodic acid-Schiff (PAS) boyası ve immunohistokimyasal olarak östrojen reseptör (ER), progesteron reseptör (PR) ve bcl-2 ile boyandı. Olgularımızın beşi kadın, biri erkek idi. En küçük yaş 34 iken, en büyük yaş 77 (ortalama yaş 53.6) olarak bulundu. Tümör boyutları Icm ile 10 cm (ortalama 6.1) arasında değişmekte idi. Tümörlerin üçü üst dış kadran, ikisi alt dış kadran, biri meme başı sağ tarafına yerleşimliydi. Dört olguda lenf nodu metastazı izlendi. Hematoksilen eozin (HE) incelenmesinde; büyük, oval yuvarlak şekilli, granüler eozinofılik stoplazmalı, nukleusları merkeze yerleşmiş, nükleolleri belirgin tümör hücrelerinin solid kitle ve kordonlar oluşturduğu izlendi. Tümör hücrelerinde PAS pozitif, ER, PR ve bcl-2 negatiftir. Bu çalışmada altı apokrin karsinom vakası sunulmaktadır.

🔖

Cite This Article

KILINÇ, N., YILMAZ, H. G., ÖZAYDIN, M. (2022). Apocrine carcinoma (Report of six cases). Anadolu Tıp Dergisi, Cilt: 5 - Sayı: 2, 83–87. https://ajindex.com/articles/438100

References (16)

  1. Abati AD, Kimmel M, Rosen PP. Apocrine Mammary Carcinoma: A clinicopathologic study of 72 cases. Am J Clin Pathol 1990
  2. Bauer TW, Rostoct RA, Eggleton JC, et al. Spindle cell carcinoma of the breast: Four cases and review of the literature. Hum Pathol 1984
  3. Gatalica Z. Immunohistochemical analysis of apocrine breast lesions. Consistent over expression of androgen receptor accompanied by the loss of estrogen and progesterone receptors in apocrine metaplasia and apocrine carcinoma in situ. Pathol Res Pract 1997
  4. Gilles R, Lesnic A, Guinebretiere J, et al. Apocrine carcinoma: Clinical and Mammographic Featuras.Radiolog 1994
  5. Jones C, Damiani S, Wells D, et al. Molecular cytogenetic comparison of apocrine hyperplasia and apocrine carcinoma of the breast. Am J Pathol 2001
  6. Leal C, Henrique R, Monteiro P, et al. Apocrine ductal carcinoma in situ of the breast: histologic classification and expression of biologic markers. Hum Pathol 2001
  7. Mazoujian G. Apocrine carcinoma of the breast. Am J Clin Pathol 1990
  8. Matsuo K, Fukutomi T, Tsuda H, et al. Apocrine Carcinoma of the Breast: Clinicopathological Analysis and Histological Subclassification of 12 Cases. Breast Cancer 1998
  9. Moriya T, Sakamoto K, Sasano H, et al. Immunohistochemical Analysis of Ki-67, p53, p21 and p27 in benign and malignant apocrine lesions of the breast: its correlation to histologic findings in 43 cases. Mod Pathol 200
  10. Mossler JA, Barton TK, Brinkhous AD, et al. Apocrin diffentiation in human mammary carsinom. Cancer 1980
  11. Ng WK. Fine needle aspiration cytology of apocrine carcinoma of the breast. Review of cases in a three-year period. Acta Cytol 2002
  12. Özcan D, Çomunoğlu C, Yetkin E ve ark. Memenin apokrin karsinomu. Haseki Tıp Bülteni 2000
  13. Roddy HJ, Silverberg SG. Ultrastructural analysis of apocrine carcinoma of the human breast. Ultrastruct Pathol 1980
  14. Rosen PP. Rosen's Breast Pathology, New York, Lippincott, Williams&Wilkins, 1997. 15-Schimitt FC, Soares R, Seruca R. Bilateral apokrin carcinoma of the breast. Virchowa Arch 1998
  15. Tavassoli FA. Pathology of the Breast 2nd edition. New York Appleton and Lange, 1999
  16. Tavassoli FA, Purceli CL, Bratthauer GL, et al. Androgen receptor positivity along "with loss of bcl-2, ER, and PR expression in benign and malignant apocrine lesions of the breast. Implicati